With a team of video production, graphic design, audiovisual, photography, web development and print services experts, BioCom supports the Health Sciences and UArizona campuses.

Richard Carmona, MD, MPH, distinguished laureate professor of public health at the Mel and Enid Zuckerman College of Public Health, writes that the COVID-19 vaccine is another in a long, well-researched and well developed history of lifesaving vaccines.

Geoffrey Ahern, MD, PhD, who held the Bruce and Lorraine Cumming Endowed Chair in Alzheimer’s Research and was a professor of neurology and psychiatry at the College of Medicine – Tucson, as well as a professor of psychology and a member of the Evelyn F. McKnight Brain Institute, recently passed away.

Tiktok has quickly become a virtual wellspring of sleep advice with the hashtag #sleephacks garnering over 200 million views on the app. But do these trending sleep hacks have any scientific standing? Michael Grandner, PhD, director of the Sleep and Health Research Program at the College of Medicine – Tucson, is quoted.

Three free webinars will focus on isolation and loneliness, integrative health and sleep as they relate to aging.

Innovations in Healthy Aging, an initiative of the University of Arizona Health Sciences, is hosting a new lecture series featuring several topics important to aging, including isolation and loneliness, integrative health and sleep. The lectures will be presented as webinars that are free and open to the public.

A new collaboration is combining the strengths of Arizona’s three public universities to advance Valley fever research and clinical care.

When, in March 2020, a science story became the biggest news story in the world, scientists became household names overnight, even celebrities. But many also became the targets of new and extreme levels of harassment, intimidation, and threats. Saskia Popescu, PhD, infectious disease epidemiologist and infection prevention expert at the Mel and Enid Zuckerman College of Public Health, is quoted.

A $1.5 million grant from the U.S. Department of Defense is supporting researchers in the University of Arizona Health Sciences Center for Innovation in Brain Science as they examine whether an investigational drug has the potential to reduce inflammation and increase the regeneration of nerve cells in people with Lou Gehrig’s disease, or ALS.